HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Balance Sheet

Financials in millions KRW. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	10,214	7,259	6,132	7,524	7,051	13,841
Short-Term Investments	-	-	-	-	-	0
Trading Asset Securities	-	-	916.26	6,030	13,217	9,022
Cash & Short-Term Investments	10,214	7,259	7,048	13,553	20,268	22,862
Cash Growth	27.29%	3.00%	-48.00%	-33.13%	-11.35%	-11.94%
Accounts Receivable	21,619	11,246	12,091	9,561	7,337	14,619
Other Receivables	-	646.92	779.81	459.59	2,388	782.8
Receivables	21,619	11,933	12,903	10,223	9,803	15,463
Inventory	26,591	28,342	27,798	26,936	18,673	17,740
Prepaid Expenses	-	557.28	733.24	579.89	433.2	1,077
Other Current Assets	2,332	1,616	1,911	3,079	1,935	1,553
Total Current Assets	60,756	49,707	50,393	54,371	51,113	58,696
Property, Plant & Equipment	41,510	43,523	44,234	46,934	46,591	47,247
Long-Term Investments	4,076	5,262	4,356	6,222	8,926	100
Goodwill	-	-	-	-	-	880.58
Other Intangible Assets	608.44	794.97	755.83	899.8	1,031	2,538
Long-Term Accounts Receivable	-	236.81	0	-	-	-
Long-Term Deferred Tax Assets	1,492	2,202	2,318	2,636	734.37	3,126
Long-Term Deferred Charges	-	-	-	-	89.19	178.38
Other Long-Term Assets	21,401	19,788	20,132	20,464	20,756	18,844
Total Assets	129,842	121,715	122,368	131,686	129,445	131,806
Accounts Payable	5,413	2,274	2,114	1,984	1,204	2,435
Accrued Expenses	1,797	1,096	947.38	841.76	743.93	769.41
Short-Term Debt	35,300	34,300	39,450	53,553	27,300	9,586
Current Portion of Long-Term Debt	-	-	-	-	9,000	-
Current Portion of Leases	743.05	1,130	942.13	1,010	740.52	562.18
Current Income Taxes Payable	319.42	848.17	109.47	320.37	-	1,483
Other Current Liabilities	14,490	10,445	21,691	16,734	22,002	13,256
Total Current Liabilities	58,062	50,092	65,253	74,443	60,991	28,092
Long-Term Debt	6,000	-	-	-	12,879	22,109
Long-Term Leases	712.37	1,000	749.26	1,347	1,658	589.35
Other Long-Term Liabilities	2,839	3,501	6,417	8,441	6,336	11,717
Total Liabilities	67,613	54,593	72,419	84,231	81,863	62,507
Common Stock	6,763	6,763	6,058	5,051	5,051	5,051
Additional Paid-In Capital	82,224	82,224	58,621	32,288	32,288	32,288
Retained Earnings	-18,707	-14,982	-7,759	15,286	9,139	25,041
Treasury Stock	-5,833	-5,833	-5,833	-5,055	-884.32	-884.32
Comprehensive Income & Other	-2,062	-1,298	-1,958	-1,937	-1,143	-1,160
Total Common Equity	62,384	66,874	49,129	45,634	44,451	60,336
Minority Interest	-154.86	248.39	819.76	1,821	3,130	8,963
Shareholders' Equity	62,229	67,122	49,949	47,455	47,581	69,299
Total Liabilities & Equity	129,842	121,715	122,368	131,686	129,445	131,806
Total Debt	42,755	36,430	41,141	55,910	51,577	32,847
Net Cash (Debt)	-32,541	-29,171	-34,093	-42,356	-31,309	-9,984
Net Cash Per Share	-2507.47	-2252.56	-3181.12	-3224.39	-3127.17	-1012.05
Filing Date Shares Outstanding	12.99	12.99	11.58	9.64	10.01	10.01
Total Common Shares Outstanding	12.99	12.99	11.58	9.64	10.01	10.01
Working Capital	2,693	-385.31	-14,860	-20,072	-9,878	30,604
Book Value Per Share	4803.56	5149.32	4243.81	4732.03	4439.82	6026.47
Tangible Book Value	61,775	66,079	48,373	44,734	43,420	56,918
Tangible Book Value Per Share	4756.71	5088.10	4178.52	4638.72	4336.84	5685.03
Land	12,571	12,459	12,542	12,525	12,525	13,308
Buildings	22,086	21,925	22,049	17,649	18,110	20,054
Machinery	22,186	20,998	19,869	8,920	7,919	6,739
Construction In Progress	1,252	1,535	1,262	1,043	1,603	2,021

Source: S&P Global Market Intelligence. Standard template. Financial Sources.